Sai Reddy, PhD student from EPFL (Ecole Polytechnique Fédérale de Lausunne) in Lausanne, Switzerland has won the KPMG Tomorrow’s Market award for a vaccination methodology he developed along with Professor Melody Swartz and Professor Jeff Hubbell. The vaccination uses nanoparticles to introduce a molecule to the immune system. The new vaccination technology is much more effective than vaccinations used today and is expected to be much cheaper. For these reasons the new vaccination can make a big difference in public health, mainly in the developing world. According to its creators, this technique will provide durable immunity after a single injection, costing around one U.S. Dollar per dose. Sai Reddy and his colleagues are already working together with the Basel-based Swiss Tropical Institute on a vaccine against malaria (a disease that kills between 1-3 million people annually worldwide). They are also looking at possible ways of adapting the method to eradicate cancer cells. For the moment, the scientists believe that it will take at least five years to turn this invention into a commercial product. https://thefutureofthings.com/3250-nanoparticles-vaccination-developed/
Market Data 
Markets 
AI
